Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study

BACKGROUND: Sodium glucose co-transporter-2 (SGLT2) inhibitors improve long-term cardiovascular and renal outcomes in individuals with type 2 diabetes. However, the safety of SGLT2 inhibitors in ICU patients with type 2 diabetes is uncertain. We aimed to perform a pilot study to assess the relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Mårtensson, Johan, Cutuli, Salvatore Lucio, Osawa, Eduardo A., Yanase, Fumitaka, Toh, Lisa, Cioccari, Luca, Luethi, Nora, Maeda, Akinori, Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186281/
https://www.ncbi.nlm.nih.gov/pubmed/37194077
http://dx.doi.org/10.1186/s13054-023-04481-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186281/
https://www.ncbi.nlm.nih.gov/pubmed/37194077
http://dx.doi.org/10.1186/s13054-023-04481-y

Ejemplares similares